In addition to being effective against induced dysmenorrhea, GZFLc inhibited COX2 activity directly, indicating COX2 enzymatic assay could be used as a bioefficacy assay for GZFLc quality controls. The gene discussed is PTGS2; the disease is Dysmenorrhea.